Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Hacd4 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | HACD4 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of HACD4 mRNA | CTD | PMID:22079256 | Hacd4 | Rat | 1,2-dichloroethane | decreases expression | ISO | Hacd4 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of HACD4 mRNA | CTD | PMID:28960355 | Hacd4 | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of HACD4 mRNA | CTD | PMID:30723492 | Hacd4 | Rat | 17beta-estradiol | increases expression | ISO | Hacd4 (Mus musculus) | 6480464 | Estradiol results in increased expression of HACD4 mRNA | CTD | PMID:19484750 | Hacd4 | Rat | 17beta-estradiol | multiple interactions | ISO | HACD4 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of HACD4 mRNA | CTD | PMID:20660070 | Hacd4 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:27291303 | Hacd4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Hacd4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to HACD4 promoter] | CTD | PMID:19654925 | Hacd4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HACD4 mRNA | CTD | PMID:33387578 | Hacd4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Hacd4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of HACD4 mRNA | CTD | PMID:21570461 | Hacd4 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | Hacd4 | Rat | 2-palmitoylglycerol | increases expression | ISO | HACD4 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of HACD4 mRNA | CTD | PMID:37199045 | Hacd4 | Rat | 3-chloropropane-1,2-diol | decreases expression | EXP | | 6480464 | alpha-Chlorohydrin results in decreased expression of HACD4 mRNA | CTD | PMID:28522335 | Hacd4 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | HACD4 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HACD4 mRNA | CTD | PMID:28628672 | Hacd4 | Rat | 3-methylcholanthrene | increases expression | ISO | Hacd4 (Mus musculus) | 6480464 | Methylcholanthrene results in increased expression of HACD4 mRNA | CTD | PMID:20713471 | Hacd4 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Hacd4 (Mus musculus) | 6480464 | bisphenol S results in increased expression of HACD4 mRNA | CTD | PMID:30951980 | Hacd4 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Hacd4 (Mus musculus) | 6480464 | Fenretinide results in increased expression of HACD4 mRNA | CTD | PMID:28973697 | Hacd4 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Hacd4 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of HACD4 mRNA | CTD | PMID:28973697 | Hacd4 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of HACD4 mRNA | CTD | PMID:24780913 and PMID:25825206 | Hacd4 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of HACD4 mRNA | CTD | PMID:31881176 | Hacd4 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of HACD4 mRNA | CTD | PMID:28959563 | Hacd4 | Rat | all-trans-retinoic acid | increases expression | ISO | HACD4 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of HACD4 mRNA | CTD | PMID:33167477 | Hacd4 | Rat | aristolochic acid A | increases expression | ISO | HACD4 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of HACD4 mRNA | CTD | PMID:33212167 | Hacd4 | Rat | arsenite(3-) | increases expression | ISO | Hacd4 (Mus musculus) | 6480464 | arsenite results in increased expression of HACD4 mRNA | CTD | PMID:18929588 | Hacd4 | Rat | arsenite(3-) | decreases expression | ISO | HACD4 (Homo sapiens) | 6480464 | arsenite results in decreased expression of HACD4 mRNA | CTD | PMID:23974009 | Hacd4 | Rat | arsenite(3-) | multiple interactions | ISO | Hacd4 (Mus musculus) | 6480464 | TRP53 protein affects the reaction [arsenite results in increased expression of HACD4 mRNA] | CTD | PMID:18929588 | Hacd4 | Rat | arsenous acid | increases expression | ISO | HACD4 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of HACD4 mRNA | CTD | PMID:26705709 | Hacd4 | Rat | atrazine | decreases expression | ISO | HACD4 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of HACD4 mRNA | CTD | PMID:22378314 | Hacd4 | Rat | benzo[a]pyrene | multiple interactions | ISO | Hacd4 (Mus musculus) | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to HACD4 promoter] | CTD | PMID:19654925 | Hacd4 | Rat | benzo[a]pyrene | increases expression | ISO | Hacd4 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of HACD4 mRNA | CTD | PMID:22228805 | Hacd4 | Rat | bilirubin IXalpha | decreases expression | ISO | HACD4 (Homo sapiens) | 6480464 | Bilirubin results in decreased expression of HACD4 mRNA | CTD | PMID:20196124 | Hacd4 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Hacd4 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of HACD4 mRNA | CTD | PMID:35716406 | Hacd4 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of HACD4 mRNA | CTD | PMID:25181051 more ... | Hacd4 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of HACD4 mRNA | CTD | PMID:34947998 | Hacd4 | Rat | bisphenol A | increases expression | ISO | HACD4 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of HACD4 mRNA | CTD | PMID:29275510 | Hacd4 | Rat | bisphenol A | increases expression | ISO | Hacd4 (Mus musculus) | 6480464 | bisphenol A results in increased expression of HACD4 mRNA | CTD | PMID:30951980 and PMID:32156529 | Hacd4 | Rat | bisphenol A | multiple interactions | ISO | HACD4 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HACD4 mRNA | CTD | PMID:28628672 | Hacd4 | Rat | bisphenol F | increases expression | ISO | Hacd4 (Mus musculus) | 6480464 | bisphenol F results in increased expression of HACD4 mRNA | CTD | PMID:30951980 | Hacd4 | Rat | carbon nanotube | decreases expression | ISO | Hacd4 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | Hacd4 | Rat | CGP 52608 | multiple interactions | ISO | HACD4 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to HACD4 gene] | CTD | PMID:28238834 | Hacd4 | Rat | choline | multiple interactions | ISO | Hacd4 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HACD4 mRNA | CTD | PMID:20938992 | Hacd4 | Rat | cisplatin | multiple interactions | ISO | Hacd4 (Mus musculus) | 6480464 | [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of HACD4 mRNA | CTD | PMID:23625948 | Hacd4 | Rat | crocidolite asbestos | decreases expression | ISO | HACD4 (Homo sapiens) | 6480464 | Asbestos and Crocidolite results in decreased expression of HACD4 mRNA | CTD | PMID:29523930 | Hacd4 | Rat | dexamethasone | multiple interactions | ISO | HACD4 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HACD4 mRNA | CTD | PMID:28628672 | Hacd4 | Rat | diarsenic trioxide | increases expression | ISO | HACD4 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of HACD4 mRNA | CTD | PMID:26705709 | Hacd4 | Rat | Dibutyl phosphate | affects expression | ISO | HACD4 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of HACD4 mRNA | CTD | PMID:37042841 | Hacd4 | Rat | dimethylarsinic acid | decreases expression | EXP | | 6480464 | Cacodylic Acid results in decreased expression of HACD4 mRNA | CTD | PMID:37567419 | Hacd4 | Rat | dioxygen | multiple interactions | ISO | Hacd4 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HACD4 mRNA | CTD | PMID:30529165 | Hacd4 | Rat | dorsomorphin | multiple interactions | ISO | HACD4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Hacd4 | Rat | doxorubicin | decreases expression | ISO | HACD4 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of HACD4 mRNA | CTD | PMID:29803840 | Hacd4 | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of HACD4 mRNA | CTD | PMID:29391264 | Hacd4 | Rat | entinostat | increases expression | ISO | HACD4 (Homo sapiens) | 6480464 | entinostat results in increased expression of HACD4 mRNA | CTD | PMID:27188386 | Hacd4 | Rat | fenamidone | increases expression | ISO | Hacd4 (Mus musculus) | 6480464 | fenamidone results in increased expression of HACD4 mRNA | CTD | PMID:27029645 | Hacd4 | Rat | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of HACD4 mRNA | CTD | PMID:30307764 | Hacd4 | Rat | fluoranthene | multiple interactions | ISO | Hacd4 (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HACD4 mRNA | CTD | PMID:28329830 | Hacd4 | Rat | folic acid | multiple interactions | ISO | Hacd4 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HACD4 mRNA | CTD | PMID:20938992 | Hacd4 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of HACD4 mRNA | CTD | PMID:33387578 | Hacd4 | Rat | hydrogen peroxide | affects expression | ISO | HACD4 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of HACD4 mRNA | CTD | PMID:21179406 | Hacd4 | Rat | indometacin | multiple interactions | ISO | HACD4 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HACD4 mRNA | CTD | PMID:28628672 | Hacd4 | Rat | L-methionine | multiple interactions | ISO | Hacd4 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HACD4 mRNA | CTD | PMID:20938992 | Hacd4 | Rat | lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of HACD4 mRNA | CTD | PMID:22641619 | Hacd4 | Rat | methylmercury chloride | decreases expression | ISO | HACD4 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of HACD4 mRNA | CTD | PMID:28001369 | Hacd4 | Rat | nickel sulfate | decreases expression | ISO | HACD4 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of HACD4 mRNA | CTD | PMID:22714537 | Hacd4 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of HACD4 mRNA | CTD | PMID:25729387 | Hacd4 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of HACD4 mRNA | CTD | PMID:33387578 | Hacd4 | Rat | phenobarbital | multiple interactions | ISO | Hacd4 (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of HACD4 mRNA] | CTD | PMID:19482888 | Hacd4 | Rat | phenobarbital | increases expression | ISO | Hacd4 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of HACD4 mRNA | CTD | PMID:19482888 | Hacd4 | Rat | phenylmercury acetate | increases expression | ISO | HACD4 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of HACD4 mRNA | CTD | PMID:26272509 | Hacd4 | Rat | phenylmercury acetate | multiple interactions | ISO | HACD4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HACD4 mRNA | CTD | PMID:27188386 | Hacd4 | Rat | pirinixic acid | decreases expression | ISO | Hacd4 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of HACD4 mRNA | CTD | PMID:23811191 | Hacd4 | Rat | potassium chromate | decreases expression | ISO | HACD4 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of HACD4 mRNA | CTD | PMID:22079256 | Hacd4 | Rat | potassium chromate | multiple interactions | ISO | HACD4 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of HACD4 mRNA | CTD | PMID:22079256 | Hacd4 | Rat | progesterone | multiple interactions | ISO | HACD4 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of HACD4 mRNA | CTD | PMID:20660070 | Hacd4 | Rat | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of HACD4 mRNA | CTD | PMID:28374803 | Hacd4 | Rat | SB 431542 | multiple interactions | ISO | HACD4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Hacd4 | Rat | silicon dioxide | decreases expression | ISO | HACD4 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of HACD4 mRNA | CTD | PMID:25895662 | Hacd4 | Rat | silicon dioxide | decreases expression | ISO | Hacd4 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of HACD4 mRNA | CTD | PMID:19073995 | Hacd4 | Rat | silver atom | decreases expression | ISO | Hacd4 (Mus musculus) | 6480464 | Silver results in decreased expression of HACD4 mRNA | CTD | PMID:27131904 | Hacd4 | Rat | silver(0) | decreases expression | ISO | Hacd4 (Mus musculus) | 6480464 | Silver results in decreased expression of HACD4 mRNA | CTD | PMID:27131904 | Hacd4 | Rat | sodium fluoride | increases expression | ISO | Hacd4 (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of HACD4 mRNA | CTD | PMID:27862939 | Hacd4 | Rat | tetrachloroethene | increases expression | ISO | Hacd4 (Mus musculus) | 6480464 | Tetrachloroethylene results in increased expression of HACD4 mRNA | CTD | PMID:28973375 | Hacd4 | Rat | tetrachloromethane | affects expression | ISO | Hacd4 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of HACD4 mRNA | CTD | PMID:17484886 | Hacd4 | Rat | tetrachloromethane | increases expression | ISO | Hacd4 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of HACD4 mRNA | CTD | PMID:27339419 more ... | Hacd4 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of HACD4 mRNA | CTD | PMID:34492290 | Hacd4 | Rat | titanium dioxide | decreases expression | ISO | Hacd4 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of HACD4 mRNA | CTD | PMID:23557971 | Hacd4 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of HACD4 mRNA | CTD | PMID:25729387 | Hacd4 | Rat | trichostatin A | increases expression | ISO | HACD4 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of HACD4 mRNA | CTD | PMID:24935251 and PMID:26272509 | Hacd4 | Rat | trichostatin A | multiple interactions | ISO | HACD4 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HACD4 mRNA | CTD | PMID:27188386 | Hacd4 | Rat | triclosan | decreases expression | ISO | HACD4 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of HACD4 mRNA | CTD | PMID:30510588 | Hacd4 | Rat | trovafloxacin | decreases expression | ISO | Hacd4 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of HACD4 mRNA | CTD | PMID:35537566 | Hacd4 | Rat | valproic acid | increases expression | ISO | HACD4 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of HACD4 mRNA | CTD | PMID:23179753 more ... | Hacd4 | Rat | valproic acid | affects expression | ISO | HACD4 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of HACD4 mRNA | CTD | PMID:25979313 | Hacd4 | Rat | valproic acid | multiple interactions | ISO | HACD4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HACD4 mRNA | CTD | PMID:27188386 | |